Home Mind & Brain Genetic Variations in Serotonin and Dopamine Impact Fear Responses

Genetic Variations in Serotonin and Dopamine Impact Fear Responses

Reading Time: 2 minutes

Recent research has uncovered critical genetic differences associated with dopamine and serotonin release that mediate fear-induced bradycardia in the human brain.

This discovery has significant implications for both neuroscientific research and clinical psychiatry, shedding light on the genetic underpinnings of heart rate variations and their potential as biomarkers for psychiatric disorders.

Following exposure to a threatening stimulus, a rapid and temporary decrease in heart rate is a physiological response known as fear-induced bradycardia. This phenomenon has been increasingly studied in fear conditioning experiments, where a neutral stimulus, when paired repeatedly with an unpleasant consequence, becomes a conditioned stimulus capable of eliciting fear responses. These responses can be measured using various techniques, such as skin conductance resistance (SCR), fear-potentiated startle (FPS), and pupillary responses (PR). But heart rate changes, particularly fear-induced bradycardia, offer a unique and consistent measure of fear responses.

The study delves into the genetic variations that influence fear-induced bradycardia. One key finding is the impact of the serotonin transporter gene (5-HTTLPR) on heart rate responses during fear conditioning. The findings were published in the journal Translational Psychiatry.

Fear-induced bradycardia was stronger in people with the short (S) allelic variant of this gene compared to those with the long (L) allelic variant. This is because the short variant is linked to less serotonin transporter function. This suggests that lower levels of serotonin transporter can enhance fear responses, highlighting the importance of genetic factors in modulating heart rate changes under threat.

Similarly, the study explored the role of dopamine, focusing on the Val158Met polymorphism of the catechol-O-methyltransferase (COMT) gene. This polymorphism affects dopamine levels in the prefrontal cortex, with individuals carrying the Val allele showing better retention of fear extinction compared to those with the Met allele. The results indicate that higher dopamine levels contribute to more effective fear extinction, reinforcing the notion that genetic differences significantly influence fear responses and heart rate variability.

The potential to use fear-induced bradycardia as a biomarker in clinical psychiatry is promising but requires cautious implementation. Psychiatric disorders often involve altered heart rate responses, and understanding the genetic basis of these changes can improve diagnostic accuracy and treatment efficacy. However, genetic differences themselves may account for variations in heart rate responses, necessitating a careful approach when integrating fear-induced bradycardia into clinical practice.

The researchers emphasise the need for further research to solidify the role of genetic differences in heart rate variations and their application in psychiatry. To make fear-induced bradycardia a more reliable clinical tool, researchers should look for more accurate genetic markers and come up with better real-time analysis and machine learning algorithms in future studies.

© Copyright 2014–2034 Psychreg Ltd